Cargando…
Transdermal delivery of nobiletin using ionic liquids
Nobiletin (NOB), a flavonoid, has extremely low water solubility and low oral bioavailability; however, despite these problems, various physiological effects have been investigated in vitro. In the present study, we investigated the transdermal delivery of NOB using choline and geranic acid (CAGE),...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934657/ https://www.ncbi.nlm.nih.gov/pubmed/31882884 http://dx.doi.org/10.1038/s41598-019-56731-1 |
_version_ | 1783483433808297984 |
---|---|
author | Hattori, Tadashi Tagawa, Hiroki Inai, Makoto Kan, Toshiyuki Kimura, Shin-ichiro Itai, Shigeru Mitragotri, Samir Iwao, Yasunori |
author_facet | Hattori, Tadashi Tagawa, Hiroki Inai, Makoto Kan, Toshiyuki Kimura, Shin-ichiro Itai, Shigeru Mitragotri, Samir Iwao, Yasunori |
author_sort | Hattori, Tadashi |
collection | PubMed |
description | Nobiletin (NOB), a flavonoid, has extremely low water solubility and low oral bioavailability; however, despite these problems, various physiological effects have been investigated in vitro. In the present study, we investigated the transdermal delivery of NOB using choline and geranic acid (CAGE), which is a biocompatible material that has been reported to be a promising transdermal delivery approach. The feasibility was evaluated by a set of in vitro and in vivo tests. A solubility evaluation demonstrated that CAGE induced excellent solubility of NOB induced by multipoint hydrogen bonding between NOB and CAGE. In vitro transdermal tests using a Franz diffusion cell showed that CAGE was effective in enhancing transdermal absorption of NOB, compared to other penetration enhancers. Subsequent in vivo tests demonstrated that CAGE significantly improved area under the concentration-time curve of NOB in vivo and NOB/CAGE sample showed 20-times higher bioavailability than oral administration of NOB crystal. Furthermore, NOB/CAGE sample also showed significant drops of the blood glucose level in rats derived from hypoglycemic activity of NOB. Thus, transdermal administration of NOB using CAGE was shown to be feasible, which indicates that the use of CAGE may be adapted for other flavonoids that also show both low water solubility and low permeability. |
format | Online Article Text |
id | pubmed-6934657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69346572019-12-30 Transdermal delivery of nobiletin using ionic liquids Hattori, Tadashi Tagawa, Hiroki Inai, Makoto Kan, Toshiyuki Kimura, Shin-ichiro Itai, Shigeru Mitragotri, Samir Iwao, Yasunori Sci Rep Article Nobiletin (NOB), a flavonoid, has extremely low water solubility and low oral bioavailability; however, despite these problems, various physiological effects have been investigated in vitro. In the present study, we investigated the transdermal delivery of NOB using choline and geranic acid (CAGE), which is a biocompatible material that has been reported to be a promising transdermal delivery approach. The feasibility was evaluated by a set of in vitro and in vivo tests. A solubility evaluation demonstrated that CAGE induced excellent solubility of NOB induced by multipoint hydrogen bonding between NOB and CAGE. In vitro transdermal tests using a Franz diffusion cell showed that CAGE was effective in enhancing transdermal absorption of NOB, compared to other penetration enhancers. Subsequent in vivo tests demonstrated that CAGE significantly improved area under the concentration-time curve of NOB in vivo and NOB/CAGE sample showed 20-times higher bioavailability than oral administration of NOB crystal. Furthermore, NOB/CAGE sample also showed significant drops of the blood glucose level in rats derived from hypoglycemic activity of NOB. Thus, transdermal administration of NOB using CAGE was shown to be feasible, which indicates that the use of CAGE may be adapted for other flavonoids that also show both low water solubility and low permeability. Nature Publishing Group UK 2019-12-27 /pmc/articles/PMC6934657/ /pubmed/31882884 http://dx.doi.org/10.1038/s41598-019-56731-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Hattori, Tadashi Tagawa, Hiroki Inai, Makoto Kan, Toshiyuki Kimura, Shin-ichiro Itai, Shigeru Mitragotri, Samir Iwao, Yasunori Transdermal delivery of nobiletin using ionic liquids |
title | Transdermal delivery of nobiletin using ionic liquids |
title_full | Transdermal delivery of nobiletin using ionic liquids |
title_fullStr | Transdermal delivery of nobiletin using ionic liquids |
title_full_unstemmed | Transdermal delivery of nobiletin using ionic liquids |
title_short | Transdermal delivery of nobiletin using ionic liquids |
title_sort | transdermal delivery of nobiletin using ionic liquids |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934657/ https://www.ncbi.nlm.nih.gov/pubmed/31882884 http://dx.doi.org/10.1038/s41598-019-56731-1 |
work_keys_str_mv | AT hattoritadashi transdermaldeliveryofnobiletinusingionicliquids AT tagawahiroki transdermaldeliveryofnobiletinusingionicliquids AT inaimakoto transdermaldeliveryofnobiletinusingionicliquids AT kantoshiyuki transdermaldeliveryofnobiletinusingionicliquids AT kimurashinichiro transdermaldeliveryofnobiletinusingionicliquids AT itaishigeru transdermaldeliveryofnobiletinusingionicliquids AT mitragotrisamir transdermaldeliveryofnobiletinusingionicliquids AT iwaoyasunori transdermaldeliveryofnobiletinusingionicliquids |